Finerenone belongs to a class of medications known as mineralocorticoid receptor antagonists. It works by blocking pathways that contribute to inflammation and scarring in the kidneys and heart.

Scientists have discovered new chronic kidney disease treatment options in 2025-2026, from finerenone for non-diabetic CKD to ...

New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and uncontrolled high ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid June 24 (Reuters) - We also report on potentially important ...

Approximately 35 million adults in the United States suffer from chronic kidney disease (CKD), and that number is growing. Meanwhile, there’s a critical shortage of nephrologists to manage these ...

We also report on new understanding of how Ebola infections may persist in the brain and other organs for months, and a troubling spread of drug-resistant bacteria outside of the ...

A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems over time. Researchers followed nearly 300,000 patients for up to 15 years ...

Approximately 35 million adults in the United States suffer from chronic kidney disease (CKD), and that number is growing. Meanwhile, there's a critical shortage of nephrologists to manage these ...